Selection of confocal immunofluorescence microscopy images. First, on the left, a macrophage infected with Brucella; second, an activated infected dendritic cell; third, an Acinetobacter baumannii-infected epithelial cell; fourth, an aggregate of an environmental Acinetobacter baumannii.

Part of our logo, multicolored bacteria

Our team studies how bacteria subvert host responses to cause disease. Our long-term goal is to unravel the molecular and cellular basis of the infectious process to develop new approaches to prevent the dissemination and virulence of these bacteria.

Logo and lab name: intrapath

Our favorite pathogens

Brucella abortus

Brucella abortus multiplying inside a human trophoblast.

Brucella causes one of the most prevalent zoonoses worldwide, still endemic in many developing countries. Brucellosis can have a severe economic impact, affecting a wide range of animals, including ruminants, swine, and dogs. The presence of brucellosis in marine and terrestrial wildlife is also of concern. Brucella can invade and extensively replicate inside host cells by injecting specific proteins that tightly control cellular functions. Despite extensive intracellular replication, Brucella species have developed exquisite mechanisms to induce or inhibit inflammation depending on the tissue context, modulate cell signaling, and interfere with host metabolism. These proteins are the focus of our research.

Acinetobacter baumannii

Human epithelial cell monolayer with attached Acinetobacter baumannii bacteria

Infections with multi-drug resistant bacteria are a leading cause of morbidity and mortality worldwide. A. baumannii is rapidly becoming a global health threat. It has a remarkable ability to persist in the environment and to acquire multi-drug resistance and virulence traits, enhancing its ability to cause life-threatening infections, particularly in intensive care units.  Recent work suggests animals may present an important reservoir for the bacteria, potentially increasing antibiotic resistance spread. Characterizing A. baumannii-host interplay, considering its human-animal-environment context, is a central topic of our lab’s research. 

News flash

October 2026

We have a new team member: welcome, Malcolm. He will be working with Varad to study effector translocation and localization.

June 2026

New BSL3 in the North building is certified! The Salcedo lab was excited to move to this new facility.

August 2026

We welcome Krystian to the lab. He will be working with Cody and amoeba, a fun new line of work in the Salcedo lab.

January 2026

Welcome to Cody Hargadon, a graduate student from the CMB program.

January 2026

New lab space!!!!!!!!!! The Salcedo lab has moved to the new Vet Med building

Recent studies support that a proportion of clinical Acinetobacter baumannii strains can multiply intracellularly. Here, we defined this transient intracellular niche, which enables efficient bacterial infection of neighboring cells and mapped the bacterial and host gene profiles, highlighting a role for the T2SS in the invasion step. We also demonstrate a remarkable ability for ABC141 to grow in low-oxygen environments.

Just out in PLOS Pathogens!